Hadassah University Medical Center — Jerusalem

Public research footprint of Hadassah University Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced or Metastatic Non-Small-Cell Lung Cancer · Leukemia · Type 2 Diabetes Mellitus · Primary Systemic (AL) Amyloidosis

Recently updated registry entries

NCT07738562 — Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility… (Not Yet Recruiting)
NCT04281485 — Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne… (Active Not Recruiting)
NCT04524871 — A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hadassah University Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.